These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6721462)

  • 1. Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.
    Guay DR; Meatherall RC; Baxter H; Jacyk WR; Penner B
    Antimicrob Agents Chemother; 1984 Mar; 25(3):306-10. PubMed ID: 6721462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
    Blevins RD; Halstenson CE; Salem NG; Matzke GR
    Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of metronidazole in patients undergoing peritoneal dialysis.
    Cassey JG; Clark DA; Merrick P; Jones B
    Antimicrob Agents Chemother; 1983 Dec; 24(6):950-1. PubMed ID: 6660863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
    Arvidsson A; Alván G; Tranaeus A; Malmborg AS
    Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and removal of metronidazole in patients undergoing haemodialysis.
    Somogyi A; Kong C; Sabto J; Gurr FW; Spicer WJ; McLean AJ
    Eur J Clin Pharmacol; 1983; 25(5):683-7. PubMed ID: 6662167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of metronidazole and its major metabolites in continuous ambulatory peritoneal dialysate.
    Bush A; Holt J; Sankey MG; Kaye CM; Gabriel R
    J Antimicrob Chemother; 1983 Sep; 12(3):294-5. PubMed ID: 6630118
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE; Frey FJ; Heizmann P; Brandt R; Weidekamm E
    Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis.
    Keller E; Jansen A; Pelz K; Hoppe-Seyler G; Schollmeyer P
    Clin Pharmacol Ther; 1984 Feb; 35(2):208-13. PubMed ID: 6692648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Morse GD; Farolino DF; Apicella MA; Walshe JJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):173-7. PubMed ID: 3566247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Joffe P; Thomsen HS; Meusel M
    Acad Radiol; 1998 Jul; 5(7):491-502. PubMed ID: 9653466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
    Barbhaiya RH; Knupp CA; Pfeffer M; Zaccardelli D; Dukes GM; Mattern W; Pittman KA; Hak LJ
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1387-91. PubMed ID: 1510432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
    Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal transport of cefonicid.
    Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
    Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Petersen J; Stewart RD; Catto GR; Edward N
    Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of quinupristin-dalfopristin in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Taylor CA; Zimmerman SW; Bridson WE; Chevalier P; Pasquier O; Baybutt RI
    Antimicrob Agents Chemother; 1999 Jan; 43(1):152-6. PubMed ID: 9869581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.